JP2000506890A5 - - Google Patents

Download PDF

Info

Publication number: JP2000506890A5
Authority: JP; Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

JP1997533496A

Other languages

English (en)

Japanese (ja)

Other versions

JP2000506890A (ja

Filing date

1997-03-21

Publication date

2004-12-02

1997-03-21 Application filed filed Critical

1997-03-21 Priority claimed from PCT/US1997/003462 external-priority patent/WO1997034878A1/en

2000-06-06 Publication of JP2000506890A publication Critical patent/JP2000506890A/ja

2004-12-02 Publication of JP2000506890A5 publication Critical patent/JP2000506890A5/ja

Status Ceased legal-status Critical Current

Links

JP9533496A 1996-03-21 1997-03-21 置換２，３―ベンゾジアゼピン―４―オンおよびその使用 Ceased JP2000506890A (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US1381396P	1996-03-21	1996-03-21
US60/013,813		1996-03-21
PCT/US1997/003462 WO1997034878A1 (en)	1996-03-21	1997-03-21	Substituted 2,3-benzodiazepin-4-ones and the use thereof

Publications (2)

Publication Number	Publication Date
JP2000506890A JP2000506890A (ja)	2000-06-06
JP2000506890A5 true JP2000506890A5 (2)	2004-12-02

Family

ID=21761900

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP9533496A Ceased JP2000506890A (ja)	1996-03-21	1997-03-21	置換２，３―ベンゾジアゼピン―４―オンおよびその使用

Country Status (11)

Country	Link
US (1)	US5891871A (2)
EP (1)	EP1021418B1 (2)
JP (1)	JP2000506890A (2)
AT (1)	ATE267177T1 (2)
AU (1)	AU2527097A (2)
DE (1)	DE69729227T2 (2)
DK (1)	DK1021418T3 (2)
ES (1)	ES2217406T3 (2)
PT (1)	PT1021418E (2)
WO (1)	WO1997034878A1 (2)
ZA (1)	ZA972496B (2)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19604919A1 (de)	1996-02-01	1997-08-07	Schering Ag	Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
DE19604920A1 (de) *	1996-02-01	1997-08-07	Schering Ag	Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
US6635632B1 (en) *	1996-12-23	2003-10-21	Athena Neurosciences, Inc.	Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
HU227128B1 (en) *	1999-07-07	2010-07-28	Egyt Gyogyszervegyeszeti Gyar	New 2,3-benzodiazepine derivatives
DE10004572A1 (de) *	2000-02-02	2001-08-09	Boehringer Ingelheim Pharma	Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
IL152848A0 (en)	2000-06-12	2003-06-24	Eisai Co Ltd	1,2-dihydropyridine derivatives, pharmaceutical compositions containing the same and methods for the production thereof
US6432944B1 (en)	2000-07-06	2002-08-13	Bristol-Myers Squibb Company	Benzodiazepinone β-amyloid inhibitors: arylacetamidoalanyl derivatives
HU225100B1 (hu) *	2000-12-21	2006-06-28	Egyt Gyogyszervegyeszeti Gyar	2,3-Benzodiazepinszármazékok, ilyen hatóanyagot tartalmazó gyógyászati készítmények és alkalmazásuk
US6649607B2 (en) *	2001-05-18	2003-11-18	Vela Pharmaceuticals, Inc.	Compositions and methods for treating or preventing convulsions or seizures
IL159105A0 (en) *	2001-06-07	2004-05-12	Neuro3D	Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
GB0129260D0 (en)	2001-12-06	2002-01-23	Eisai London Res Lab Ltd	Pharmaceutical compositions and their uses
US7022700B2 (en) *	2002-12-03	2006-04-04	Vela Pharmaceuticals, Inc.	Method of increasing neutrophil production using optically-pure (R)-2,3-benzodiazepines
CA2510275A1 (en) *	2002-12-03	2004-08-19	Vela Pharmaceuticals, Inc.	Pharmaceutical composition of 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5h-2,3-benzodiazepine and uses therof
US6638928B1 (en)	2002-12-03	2003-10-28	Vela Pharmaceuticals, Inc.	Treatment of irritable bowel syndrome and nonulcer dyspepsia with substituted 2,3-benzodiazepines
AU2003293405A1 (en) *	2002-12-03	2004-06-23	Vela Pharmaceuticals, Inc.	Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5h-2,3-benzodiazepine and uses thereof
US6864251B2 (en) *	2002-12-03	2005-03-08	Vela Pharmaceuticals, Inc.	Treatment of LTB4-mediated inflammatory disorders with optically-pure (R)-2,3-benzodiazepines
KR20050094840A (ko)	2003-01-13	2005-09-28	코텍스 파마슈티칼스, 인크.	수면 부족 및 스트레스로 인한 인식 저하의 치료방법
US20040152694A1 (en) *	2003-02-04	2004-08-05	Istvan Kurucz	Methods and compositions for treating inflammatory disorders of the airways
US20040162284A1 (en) *	2003-02-19	2004-08-19	Harris Herbert W.	Method of lowering body temperature with (S) tofisopam
US20040224943A1 (en) *	2003-02-19	2004-11-11	Leventer Steven M.	Method of lowering body temperature with (R) - 2,3-benzodiazepines
GB0325175D0 (en) *	2003-10-28	2003-12-03	Novartis Ag	Organic compounds
MY148809A (en)	2004-07-06	2013-05-31	Eisai R&D Man Co Ltd	Crystals of 1,2-dihydropyridine compound and their production process
JP2007153755A (ja) *	2005-12-01	2007-06-21	Gifu Univ	プロリン類縁体
EP2338492A1 (en)	2009-12-24	2011-06-29	Universidad del Pais Vasco	Methods and compositions for the treatment of alzheimer
FR2972454B1 (fr) *	2011-03-08	2013-03-01	Servier Lab	Nouveaux derives dihydro-oxazolobenzodiazepinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2014026997A1 (de)	2012-08-16	2014-02-20	Bayer Pharma Aktiengesellschaft	2,3-benzodiazepine
CA2901352A1 (en)	2013-02-19	2014-08-28	Bayer Pharma Aktiengesellschaft	Bicyclo 2,3-benzodiazepines and spirocyclically substituted 2,3-benzodiazepines
US20160009725A1 (en)	2013-02-22	2016-01-14	Bayer Pharma Aktiengesellschaft	Pyrrolo- and pyrazolo-triazolodiazepines as bet-protein inhibitors for treating hyperproliferative diseases
EP2958923A1 (de)	2013-02-22	2015-12-30	Bayer Pharma Aktiengesellschaft	4-substituierte pyrrolo- und pyrazolo-diazepine
EP3008167A4 (en)	2013-06-13	2017-06-07	VeroScience LLC	Compositions and methods for treating metabolic disorders
EP3436021A4 (en)	2016-03-29	2019-11-06	RespireRx Pharmaceuticals Inc.	COMPOSITIONS AND METHODS FOR TREATING ATTENTION DEFICIT DISORDER
WO2020124090A1 (en)	2018-12-14	2020-06-18	Eisai R&D Management Co., Ltd.	Aqueous based pharmaceutical formulations of 1,2-dihydropyridine compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2085645A1 (en) *	1970-04-22	1971-12-31	Chimidrog	1-phenyl-2,3-benzodiazepin-4-ones - as tranquillizers
HU191698B (en) *	1984-07-27	1987-03-30	Gyogyszerkutato Intezet	Process for producing new 1-aryl-5h-2beta-benzodiazepines
HU198494B (en) *	1986-08-15	1989-10-30	Gyogyszerkutato Intezet	Process for producing new 3,4-dihydro-5h-2,3-benzodiazepine derivative and acid addition salts thereof, as well as pharmaceutical compositions comprising same
HU219778B (hu) *	1990-12-21	2001-07-30	Gyógyszerkutató Intézet Közös Vállalat	Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
US5550124A (en) *	1991-12-10	1996-08-27	University Of Southern California	Use of peripheral-type benzodiazpine sites for treatment of CNS trauma or disease
US5922773A (en) *	1992-12-04	1999-07-13	The Children's Medical Center Corp.	Glaucoma treatment
DE19604920A1 (de) *	1996-02-01	1997-08-07	Schering Ag	Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel

1997
- 1997-03-20 US US08/821,638 patent/US5891871A/en not_active Expired - Fee Related
- 1997-03-21 DE DE69729227T patent/DE69729227T2/de not_active Expired - Fee Related
- 1997-03-21 ES ES97916722T patent/ES2217406T3/es not_active Expired - Lifetime
- 1997-03-21 WO PCT/US1997/003462 patent/WO1997034878A1/en not_active Ceased
- 1997-03-21 JP JP9533496A patent/JP2000506890A/ja not_active Ceased
- 1997-03-21 DK DK97916722T patent/DK1021418T3/da active
- 1997-03-21 PT PT97916722T patent/PT1021418E/pt unknown
- 1997-03-21 AT AT97916722T patent/ATE267177T1/de not_active IP Right Cessation
- 1997-03-21 EP EP97916722A patent/EP1021418B1/en not_active Expired - Lifetime
- 1997-03-21 AU AU25270/97A patent/AU2527097A/en not_active Abandoned
- 1997-03-24 ZA ZA9702496A patent/ZA972496B/xx unknown

Publication	Publication Date	Title
JP2000516516A5 (2)	2005-04-07
JP2000513396A5 (2)	2005-02-10
JP2001506095A5 (2)	2005-08-11
JP2000515550A5 (2)	2005-04-07
JP2000516626A5 (2)	2005-04-07
JP2000509281A5 (2)	2005-01-13
JP2001502526A5 (2)	2005-06-16
JP2000516033A5 (2)	2004-11-18
JP2000507945A5 (2)	2004-11-18
JP2001502424A5 (2)	2005-05-12
JP2000508006A5 (2)	2004-12-02
JP2001503197A5 (2)	2005-05-12
JP2001507222A5 (2)	2005-08-11
JP2001505597A5 (2)	2005-06-16
JP2000508995A5 (2)	2004-12-09
JP2001506611A5 (2)	2005-08-11
JP2000509810A5 (2)	2005-01-13
JP2000510766A5 (2)	2005-01-13
JP2001502025A5 (2)	2005-03-10
JP2001501364A5 (2)	2005-01-13
JP2001503266A5 (2)	2005-05-12
JP2000510858A5 (2)	2004-12-09
JP2000510507A5 (2)	2004-12-09
JP2000505072A5 (2)	2004-11-11
JP2000511953A5 (2)	2005-01-13